Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements), 2015, further to letter dated 28.09.2022, Vivimed Labs has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Monday, 14th Day of November, 2022 at Hyderabad to consider and approve un-audited Financial Results (Standalone & Consolidated) of the company for the quarter and half year ended 30th September, 2022. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has intimated its ‘Designated Persons including Directors’ regarding the closure of trading window from 01.10.2022 to till 48 hours after the declaration of un-audited Financial Results (Standalone & Consolidated) of the company for the quarter and half year ended 30th September, 2022.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: